• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures

Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures

by Truveta staff | May 21, 2025 | Research

A recent analysis using Truveta Data reveals that patients undergoing high-risk, non-emergency heart procedures (percutaneous coronary intervention, or PCI) with support from the Impella heart pump had better outcomes than those supported with an intra-aortic balloon...

Share this


Recent posts

  • Truveta Experts: Real-world trends in Rituxan biosimilar adoption
  • Shifting trends in initiation of disease-modifying therapies for multiple sclerosis
  • New AAP guidelines are changing pediatric obesity treatment—but there’s still work to do

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.